Skip to main navigation Skip to search Skip to main content

Biosimilars are essential for sustainable healthcare systems; however, key challenges remain as seen with long-acting insulin analogues

  • Brian Godman*
  • , Biljana Tubic
  • , Eleonora Allocati
  • , Magdalene Wladysiuk
  • , Stuart McTaggart
  • , Amanj Kurdi
  • , Mainul Haque
  • , Sean MacBride-Stewart
  • , Francis Kalemeera
  • , Amos Massele
  • , Iris Hoxha
  • , Vanda Markovic Pekovic
  • , Guenka Petrova
  • , Konstantin Tachkov
  • , Ott Laius
  • , András Harsanyi
  • , András Inotai
  • , Arianit Jakupi
  • , Svens Henkuzens
  • , Kristina Garuolienė
    • Patricia Vella Bonanno, Jakub Rutkowski, Ileana Mardare, Jurij Fürst, Caridad Pontes, Corinne Zara, Marta Turu Pedrola, Farhana Akter, Hye Young Kwon, Antony P. Martin, Rita Banzi, Janney Wale, Jolanta Gulbinovič
*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

7 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Biosimilars are essential for sustainable healthcare systems; however, key challenges remain as seen with long-acting insulin analogues'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Agricultural and Biological Sciences